Quaker Wealth Management
SNOA icon

Quaker Wealth Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Quaker Wealth Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4 Hold
3
– – ﹤0.01% 955
2026
Q2 		$4 Hold
3
– – ﹤0.01% 968
2026
Q1 		$7 Hold
3
– – ﹤0.01% 971
2025
Q4 		$11 Hold
3
– – ﹤0.01% 964
2025
Q3 		$12 Hold
3
– – ﹤0.01% 838
2025
Q2 		$9 Buy
+3
New +$9 ﹤0.01% 865

Other funds holding SNOA

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
McKinley Carter Wealth Services
McKinley Carter Wealth Services Wheeling, West Virginia $1.96B AUM 13.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Harbour Investments
Harbour Investments Madison, Wisconsin $6.75B AUM 16.25% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Quaker Wealth Management's SNOA Position: Q3 2026 in Review

Quaker Wealth Management held its Sonoma Pharmaceuticals (SNOA) position steady in Q3 2026 at 3 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #955.

Quaker Wealth Management first reported a position in SNOA in Q2 2025 and has held it in 6 quarters since. The position peaked at $12 in Q3 2025. 10 funds tracked by Wall St. Rank hold SNOA as of Q3 2026.

  • Quaker Wealth Management held 3 shares of Sonoma Pharmaceuticals worth $4 as of Q3 2026.
  • Quaker Wealth Management left its Sonoma Pharmaceuticals share count unchanged in Q3 2026.
  • Sonoma Pharmaceuticals made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #955 holding.
  • Quaker Wealth Management first reported a position in Sonoma Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • Quaker Wealth Management's Sonoma Pharmaceuticals position peaked at $12 in Q3 2025.
  • 10 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.